Five Takeaways From The 2026 J.P. Morgan Healthcare Conference
The author Juergen Eckhardt, pictured center, speaking this week at a panel on medical innovation hosted by the…
Zee Laboratories’ cheap medicines plagued by serious quality…
Part of this inaction can be explained by government guidelines that discourage regulators from prosecuting a company for…
Greed Is a Hell of a Drug
On Sept. 24, the California-based multinational corporation Gilead Sciences announced it would lower the price of lenacapavir — a…